← All organizations
Yichang Humanwell Pharmaceutical Co.,Ltd
For profit
Also known as: HUMANWELL PHARMACEUTICAL US INC | HUMANWELL PURACAP | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company | WUHAN HUMANWELL LIKANG PHARMACEUTICAL CO. LTD. | YICHANG HUMANWELL | Yichang Humanwell Pharmaceutical Co.,Ltd | Yichang Humanwell Pharmaceutical Co., Ltd., China
Highest phase reached
Phase 4
Timeline
Drugs by trial phase (11 distinct, 9 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Marketed drugs (24)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (9)
- NCT06882135Lead sponsorPhase 1Mar 19, 2025
- NCT06949059CollaboratorPhase 1/Phase 2Jan 1, 2025
- NCT06153498CollaboratorPhase 2Nov 4, 2023
- NCT06785571CollaboratorPhase 2/Phase 3Aug 30, 2023
- NCT05782894CollaboratorPhase 3Mar 1, 2023
- NCT05624424CollaboratorPhase 4Nov 15, 2022
- NCT06124404CollaboratorPhase 2Apr 8, 2022
- NCT04947345CollaboratorPhase 3Sep 1, 2021
- NCT02635802CollaboratorPhase 4Dec 1, 2015
Details
- Founded
- Hubei, CN Jun 1, 1954
- Last known activity
- May 4, 2026